2017 annual financial data
Nektar Therapeutics 2017 Operating margin
Nektar Therapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was -19.38%.
Operating income was -59,642,000 USD and net income was -96,692,000 USD.
Operating cash flow was -80,414,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 307,711,000 USD
- Operating income
- -59,642,000 USD
- Net income
- -96,692,000 USD
- Operating cash flow
- -80,414,000 USD